Clinical Trials Logo

Clinical Trial Summary

CT enterography has become an important tool in the evaluation of small bowel diseases, especially in patients with inflammatory bowel diseases. There are several shortcomings of commonly used isotonic mannitol as an oral contrast agent, such as incident adverse reactions and gases in the gut. However, polyethylene glycol can avoid these drawbacks with a good performance in some pilot experiments.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03495804
Study type Interventional
Source Shandong University
Contact Yanqing Li, PhD, MD
Phone 86-531-82169236
Status Recruiting
Phase N/A
Start date November 1, 2017
Completion date October 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03808649 - Individualized Volume of Oral Contrast Agent in CT Enterography N/A